Nephros Total Liab vs Cash And Short Term Investments Analysis

NEPH Stock

USD 1.51 0.01 0.67%

Nephros financial indicator trend analysis is infinitely more than just investigating Nephros recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nephros is a good investment. Please check the relationship between Nephros Total Liab and its Cash And Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.

Total Liab vs Cash And Short Term Investments

Total Liab vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nephros Total Liab account and Cash And Short Term Investments. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Nephros' Total Liab and Cash And Short Term Investments is -0.06. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Nephros, assuming nothing else is changed. The correlation between historical values of Nephros' Total Liab and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Nephros are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Liab i.e., Nephros' Total Liab and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.06

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Nephros balance sheet. This account contains Nephros investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Nephros fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Nephros' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nephros current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.The Nephros' current Issuance Of Capital Stock is estimated to increase to about 6 M, while Selling General Administrative is projected to decrease to under 5.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	5.7M	4.7M	8.4M	8.8M
Total Revenue	10.4M	10.0M	14.2M	14.9M

Gross Profit Total Revenue

Nephros fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Other Assets	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Preferred Stock Total Equity	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.21	-0.06	-0.24	0.98	-0.12	0.8	0.63	-0.07	0.4	-0.23	0.61	0.58	0.88	0.68	-0.58	-0.92	-0.61	0.89	-0.49	0.98	-0.23	-0.43	0.7	0.54	0.99
Other Current Liab	0.21		0.39	0.41	0.08	0.38	0.17	0.38	0.29	0.36	-0.23	0.2	0.18	0.3	0.23	-0.05	-0.18	-0.4	0.46	0.47	0.11	-0.24	-0.14	0.32	0.23	0.13
Total Current Liabilities	-0.06	0.39		0.53	-0.1	0.33	-0.3	-0.04	0.09	0.04	-0.27	-0.07	0.29	-0.11	-0.17	0.44	0.18	0.24	0.1	0.34	-0.12	-0.27	0.14	-0.18	-0.15	-0.1
Accounts Payable	-0.24	0.41	0.53		-0.31	0.03	-0.37	-0.02	0.09	-0.38	-0.29	-0.09	-0.23	-0.38	-0.21	-0.02	0.3	0.52	-0.07	0.32	-0.33	-0.29	0.18	-0.49	-0.2	-0.26
Cash	0.98	0.08	-0.1	-0.31		-0.1	0.74	0.58	-0.06	0.32	-0.18	0.51	0.58	0.84	0.62	-0.56	-0.94	-0.54	0.8	-0.53	0.99	-0.18	-0.37	0.63	0.49	0.99
Other Assets	-0.12	0.38	0.33	0.03	-0.1		-0.47	0.01	0.45	0.1	-0.26	-0.48	0.0	-0.19	-0.29	0.45	0.01	0.16	-0.07	0.66	-0.12	-0.27	0.39	-0.1	-0.3	-0.15
Common Stock Shares Outstanding	0.8	0.17	-0.3	-0.37	0.74	-0.47		0.44	-0.16	0.44	-0.07	0.81	0.48	0.86	0.85	-0.74	-0.68	-0.82	0.74	-0.62	0.78	-0.07	-0.46	0.75	0.79	0.78
Other Current Assets	0.63	0.38	-0.04	-0.02	0.58	0.01	0.44		-0.12	0.21	-0.29	0.4	-0.09	0.63	0.37	-0.43	-0.73	-0.39	0.6	0.0	0.58	-0.3	-0.26	0.44	0.28	0.61
Total Liab	-0.07	0.29	0.09	0.09	-0.06	0.45	-0.16	-0.12		0.19	0.02	-0.12	0.05	-0.31	-0.11	0.13	0.03	-0.08	0.1	0.4	-0.06	0.02	0.55	0.04	-0.09	-0.12
Preferred Stock Total Equity	0.4	0.36	0.04	-0.38	0.32	0.1	0.44	0.21	0.19		0.19	0.26	0.41	0.51	0.3	0.02	-0.27	-0.76	0.6	0.1	0.3	0.19	-0.35	0.84	0.32	0.29
Common Stock	-0.23	-0.23	-0.27	-0.29	-0.18	-0.26	-0.07	-0.29	0.02	0.19		-0.48	-0.05	-0.14	-0.49	0.26	0.24	-0.18	-0.23	0.01	-0.19	1.0	-0.16	0.2	-0.44	-0.24
Property Plant Equipment	0.61	0.2	-0.07	-0.09	0.51	-0.48	0.81	0.4	-0.12	0.26	-0.48		0.38	0.65	0.91	-0.64	-0.48	-0.56	0.64	-0.51	0.56	-0.48	-0.31	0.45	0.87	0.59
Short Long Term Debt Total	0.58	0.18	0.29	-0.23	0.58	0.0	0.48	-0.09	0.05	0.41	-0.05	0.38		0.56	0.49	-0.04	-0.38	-0.47	0.55	-0.33	0.59	-0.06	-0.31	0.47	0.43	0.56
Total Stockholder Equity	0.88	0.3	-0.11	-0.38	0.84	-0.19	0.86	0.63	-0.31	0.51	-0.14	0.65	0.56		0.76	-0.51	-0.82	-0.77	0.78	-0.45	0.86	-0.15	-0.62	0.77	0.68	0.87
Property Plant And Equipment Net	0.68	0.23	-0.17	-0.21	0.62	-0.29	0.85	0.37	-0.11	0.3	-0.49	0.91	0.49	0.76		-0.71	-0.6	-0.6	0.64	-0.51	0.67	-0.49	-0.28	0.47	0.98	0.68
Current Deferred Revenue	-0.58	-0.05	0.44	-0.02	-0.56	0.45	-0.74	-0.43	0.13	0.02	0.26	-0.64	-0.04	-0.51	-0.71		0.54	0.34	-0.51	0.51	-0.58	0.26	0.09	-0.29	-0.65	-0.6
Net Debt	-0.92	-0.18	0.18	0.3	-0.94	0.01	-0.68	-0.73	0.03	-0.27	0.24	-0.48	-0.38	-0.82	-0.6	0.54		0.52	-0.72	0.4	-0.95	0.24	0.4	-0.58	-0.48	-0.94
Retained Earnings	-0.61	-0.4	0.24	0.52	-0.54	0.16	-0.82	-0.39	-0.08	-0.76	-0.18	-0.56	-0.47	-0.77	-0.6	0.34	0.52		-0.69	0.2	-0.57	-0.17	0.46	-0.93	-0.57	-0.55
Non Current Assets Total	0.89	0.46	0.1	-0.07	0.8	-0.07	0.74	0.6	0.1	0.6	-0.23	0.64	0.55	0.78	0.64	-0.51	-0.72	-0.69		-0.21	0.78	-0.23	-0.33	0.78	0.52	0.82
Non Currrent Assets Other	-0.49	0.47	0.34	0.32	-0.53	0.66	-0.62	0.0	0.4	0.1	0.01	-0.51	-0.33	-0.45	-0.51	0.51	0.4	0.2	-0.21		-0.55	0.0	0.4	-0.19	-0.45	-0.56
Cash And Short Term Investments	0.98	0.11	-0.12	-0.33	0.99	-0.12	0.78	0.58	-0.06	0.3	-0.19	0.56	0.59	0.86	0.67	-0.58	-0.95	-0.57	0.78	-0.55		-0.19	-0.38	0.62	0.55	0.99
Common Stock Total Equity	-0.23	-0.24	-0.27	-0.29	-0.18	-0.27	-0.07	-0.3	0.02	0.19	1.0	-0.48	-0.06	-0.15	-0.49	0.26	0.24	-0.17	-0.23	0.0	-0.19		-0.16	0.2	-0.44	-0.24
Non Current Liabilities Total	-0.43	-0.14	0.14	0.18	-0.37	0.39	-0.46	-0.26	0.55	-0.35	-0.16	-0.31	-0.31	-0.62	-0.28	0.09	0.4	0.46	-0.33	0.4	-0.38	-0.16		-0.51	-0.24	-0.43
Other Stockholder Equity	0.7	0.32	-0.18	-0.49	0.63	-0.1	0.75	0.44	0.04	0.84	0.2	0.45	0.47	0.77	0.47	-0.29	-0.58	-0.93	0.78	-0.19	0.62	0.2	-0.51		0.4	0.63
Property Plant And Equipment Gross	0.54	0.23	-0.15	-0.2	0.49	-0.3	0.79	0.28	-0.09	0.32	-0.44	0.87	0.43	0.68	0.98	-0.65	-0.48	-0.57	0.52	-0.45	0.55	-0.44	-0.24	0.4		0.54
Total Current Assets	0.99	0.13	-0.1	-0.26	0.99	-0.15	0.78	0.61	-0.12	0.29	-0.24	0.59	0.56	0.87	0.68	-0.6	-0.94	-0.55	0.82	-0.56	0.99	-0.24	-0.43	0.63	0.54

Click cells to compare fundamentals

Nephros Account Relationship Matchups

Nephros fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.6M	18.5M	17.7M	11.0M	11.9M	7.5M
Other Current Liab	300K	341K	448K	268K	312K	456.2K
Total Current Liabilities	2.4M	1.3M	2.4M	1.4M	2.1M	1.6M
Accounts Payable	959K	423K	1.3M	740K	873K	711.0K
Cash	4.2M	8.2M	7.0M	3.6M	4.3M	2.7M
Other Assets	32K	1.8M	89K	54K	62.1K	59.0K
Common Stock Shares Outstanding	7.5M	9.1M	10.0M	10.3M	10.4M	10.9M
Other Current Assets	61K	237K	558K	188K	132K	161.6K
Total Liab	3.9M	2.9M	2.9M	2.1M	3.5M	2.9M
Property Plant Equipment	1.2M	295K	1.1M	1.1M	1.3M	1.3M
Short Long Term Debt Total	2.5M	2.2M	1.1M	1.1M	1.8M	1.7M
Total Stockholder Equity	4.7M	12.5M	11.7M	5.6M	8.4M	8.8M
Property Plant And Equipment Net	1.2M	1.3M	1.1M	1.1M	2.0M	2.1M
Net Debt	(1.6M)	(6.1M)	(5.9M)	(2.5M)	(2.5M)	(2.3M)
Retained Earnings	(127.3M)	(131.9M)	(135.7M)	(142.8M)	(144.4M)	(151.6M)
Non Current Assets Total	3.3M	3.4M	4.0M	2.7M	3.5M	1.8M
Non Currrent Assets Other	18K	32K	89K	54K	86K	81.7K
Cash And Short Term Investments	4.2M	8.2M	7.0M	3.6M	4.3M	3.7M
Liabilities And Stockholders Equity	11.6M	18.5M	17.7M	11.0M	11.9M	7.8M
Non Current Liabilities Total	1.5M	1.6M	511K	706K	1.4M	2.0M
Other Stockholder Equity	131.9M	144.3M	147.3M	148.4M	152.8M	109.1M
Property Plant And Equipment Gross	1.2M	1.3M	1.1M	1.1M	2.9M	3.1M
Total Current Assets	8.3M	15.2M	13.6M	8.3M	8.4M	6.1M
Short Term Debt	1.2M	1.0M	561K	387K	892K	744.8K
Inventory	2.6M	5.3M	4.8M	3.2M	2.5M	1.4M
Net Receivables	1.0M	1.4M	1.6M	1.3M	1.5M	806.7K
Long Term Debt	623K	846K	95K	1K	900.0	855.0
Intangible Assets	1.4M	1.2M	2.1M	825K	652K	1.1M
Net Tangible Assets	2.6M	10.6M	8.9M	4.0M	4.6M	2.7M
Capital Surpluse	122.9M	127.8M	131.9M	144.3M	165.9M	134.3M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:

How To Invest In Nephros

Details

Is Nephros Stock a good investment?

Details

What is Nephros' Net Worth?

Details

Largest Medical Instruments & Supplies Companies

View

Largest Consumer Discretionary Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.09)

Revenue Per Share

1.313

Quarterly Revenue Growth

(0.08)

Return On Assets

(0.08)

Return On Equity

(0.16)

The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nephros Total Liab vs Cash And Short Term Investments Analysis

Total Liab vs Cash And Short Term Investments

Total Liab vs Cash And Short Term Investments Correlation Analysis

Correlation Coefficient

Total Liab

Cash And Short Term Investments

Nephros fundamental ratios Correlations

Nephros Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nephros fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Cash	+ 0.98	Total Assets

Cash And Short Term Investments	- 0.95	Net Debt
Total Current Assets	- 0.94	Net Debt
Net Debt	- 0.94	Cash
Other Stockholder Equity	- 0.93	Retained Earnings
Net Debt	- 0.92	Total Assets
Net Debt	- 0.82	Total Stockholder Equity